Hong Kong stocks rise as positive holiday bias sets in ahead of Lunar New Year



Hong Kong stocks rose on Wednesday, supported by holiday-related flows ahead of the Lunar New Year break, with investors adjusting positions as the market heads into a shortened trading schedule next week.

The Hang Seng Index rose 0.2 per cent to 27,246.18 at the open, adding to the 0.6 per cent gain recorded on Tuesday. The Hang Seng Tech Index climbed 0.2 per cent. On the mainland, the CSI 300 Index and the Shanghai Composite Index were little changed.

Wuxi Biologics jumped 3.6 per cent to HK$41.44 after reporting a nearly 22 per cent rise in net profit, beating market expectations. Techtronic Industries rose 1.8 per cent to HK$116.40, and Innovent Biologics surged 1.4 per cent to HK$90.90. Short-video sharing platform Kuaishou Technology added 1.4 per cent to HK$71.35, and blind-box toymaker Pop Mart International advanced 1.3 per cent to HK$273.20.

Chinese chipmaker SMIC lost 2.4 per cent to HK$69.85 after fourth quarter net income missed estimates. WeChat operator Tencent Holdings slid 1.5 per cent to HK$543, and online travel-booking agency Trip.com declined 1.5 per cent to HK$442.

Hong Kong stocks will trade for only half a day on Monday before closing for the holiday, reinforcing near-term calendar effects on market moves. The benchmark typically sees lighter volumes and a positive bias ahead of the holiday, as traders square positions and selectively add exposure before the break.

Two stocks debuted on Wednesday. Wuxi Lead Intelligent Equipment added 1 per cent to HK$46.26 in Hong Kong, and Isvision (Hangzhou) Technology advanced 8 per cent to 100 yuan in Shanghai.

  • Related Posts

    China lets yuan rise to strongest level in years as de-dollarisation trend grows

    China’s central bank set the yuan’s daily fixing rate at its strongest level since mid-2023 on Wednesday, as the Chinese currency extended gains with investors increasingly rotating out of US…

    Continue reading
    Fosun Health to build first overseas hospitals in Indonesia amid Chinese ‘go global’ push

    Fosun Health Group, a subsidiary of Fosun Pharmaceutical, said it plans to build its first overseas hospitals in Indonesia amid a push by Chinese healthcare companies to expand abroad. The…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *